60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue

• Source: NewsAPI.org • 19 words, ~1 min read

60 Degrees Pharma reports DSMB recommends continuing the B-FREE Phase 2 chronic babesiosis study after finding no safety concerns....